OX40 Ligand/TNFSF4 Antibody (oxelumab) [Janelia Fluor™ 669], Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB527884-Each-of-1 | In Stock | ₹ 33,747.02 |
NB527884 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 33,747.02
GST (18%): ₹ 6,074.464
Total Price: ₹ 39,821.484
Antigen
OX40 Ligand/TNFSF4
Classification
Monoclonal
Conjugate
Janelia Fluor 669
Gene Alias
CD134 ligand, CD134L, CD252, CD252 antigen, Glycoprotein Gp34, gp34, OX40 antigen ligand, OX40 ligand, OX40L, OX-40L, OX4OL, TAX transcriptionally-activated glycoprotein 1, tax-transcriptionally activated glycoprotein 1 (34kD), tax-transcriptionally activated glycoprotein 1, 34kD, tumor necrosis factor (ligand) superfamily, member 4, tumor necrosis factor ligand superfamily member 4, TXGP1
Immunogen
TNFSF4/ OX40L/ CD252
Quantity
0.1 mL
Research Discipline
Cancer, Cell Cycle and Replication, Immunology
Gene ID (Entrez)
7292
Content And Storage
Store at 4°C in the dark.
Isotype
IgG1
Applications
Flow Cytometry, ELISA, Functional Assay
Clone
oxelumab
Formulation
50mM Sodium Borate
Host Species
Human
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Related Products
Description
- OX40 Ligand/TNFSF4 Monoclonal antibody specifically detects OX40 Ligand/TNFSF4 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay